Researchers have created a single nanoparticle that can be tracked in real time with MRI as it homes in on cancer cells, tags them with a fluorescent dye and kills them with heat.
Federal health advisers said that expanded use of AstraZeneca's cholesterol pill Crestor can benefit patients with healthy cholesterol levels by preventing heart attack, stroke and death.
Federal health advisers recommended against expanding approval of an OSI Pharmaceuticals lung cancer drug Tarceva to patients who are already responding to chemotherapy. The drugmaker's shares fell almost 7 percent in afternoon trading.
The Boards of Silence Therapeutics plc and Intradigm Corporation announced the merger of their businesses to form a leading company in the field of RNAi (RNA interference).
Research teams led by the Wellcome Trust Sanger Institute announce the first comprehensive analyses of genomes of a malignant melanoma and a lung cancer revealing essentially all the mutations in the genomes of two cancers.
Tris Pharma announced that the FDA has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+ platform technology including the first-ever 24 hour liquid sustained release product.
Q Chip is developing a range of sustained-release biosimilars using its patented Q-Sphera bioencapsulation platform for peptide and protein delivery.
Intercell and GlaxoSmithKline Biologicals SA (GSK) agreed to form a strategic alliance to accelerate the development and commercialization of needle-free, patch-based vaccines.
Delivery Science recently announced a partnership with the University of Rhode Island’s College of Pharmacy to expand the company’s formulation and analytical testing capabilities.
Rules-Based Medicine (RBM), a multiplexed biomarker testing laboratory, launched CardiovascularMAP, a research tool designed specifically to advance drug development aimed at the treatment of cardiovascular disease.
Gilead Sciences, Inc. announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints.
Scientists at the European Molecular Biology Laboratory are the first to prove that the Notch signaling pathway targets heart muscle cells, reavaling its crucial role in heart development and repair.
Aterovax SA, announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease over a five-year period.
Abbott announced three-year data demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries
Hundreds of thousands of swine flu shots for children have been recalled because tests indicate the vaccine doses lost some strength, government health officials said Tuesday